Public stock offering pulls in $22.6M for InspireMD

04/23/2013 | MassDevice.com (Boston)

InspireMD has secured net proceeds of $22.6 million in a public offering of company shares. The Israeli device firm will use part of the funding to seek FDA approval of its MGuard carotid and coronary stents, which are used to prevent the risk of embolism in patients who have undergone stenting procedures.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN